Racial disparities in advanced-stage colorectal cancer survival |
| |
Authors: | Kristin Wallace Elizabeth G. Hill David N. Lewin Grace Williamson Stephanie Oppenheimer Marvella E. Ford Michael J. Wargovich Franklin G. Berger Susan W. Bolick Melanie B. Thomas Anthony J. Alberg |
| |
Affiliation: | 1. Division of Epidemiology and Biostatistics, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA 2. Department of Pathology, Medical University of South Carolina, Charleston, SC, USA 3. Department of Pharmacology, Medical University of South Carolina, Charleston, SC, USA 4. Department of Biological Sciences, Center for Colon Cancer Research, University of South Carolina, Columbia, SC, USA 5. South Carolina Central Cancer Registry, Columbia, SC, USA 6. Division of Medical Oncology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA
|
| |
Abstract: | Purpose African-Americans (AA) have a higher incidence of and lower survival from colorectal cancer (CRC) compared with European Americans (EA). In the present study, statewide, population-based data from South Carolina Central Cancer Registry are used to investigate the relationship between race and age on advanced-stage CRC survival. Methods The study population was comprised of 3,865 advanced pathologically documented colon and rectal adenocarcinoma cases diagnosed between 01 January 1996 and 31 December 2006: 2,673 (69 %) EA and 1,192 (31 %) AA. Kaplan–Meier methods were used to generate median survival time and corresponding 95 % confidence intervals (CI) by race, age, and gender. Factors associated with survival were evaluated by fitting Cox proportional hazards regression models to generate hazard ratios (HR) and 95 % CI. Results We observed a significant interaction between race and age on CRC survival (p = 0.04). Among younger patients (<50 years), AA race was associated with a 1.34 times (95 % CI 1.06–1.71) higher risk of death compared with EA. Among older patients, we observed a modest increase in risk of death among AA men compared with EA [HR 1.16 (95 % CI 1.01–1.32)] but no difference by race between women [HR 0.94 (95 % CI 0.82–1.08)]. Moreover, we observed that the disparity in survival has worsened over the past 15 years. Conclusions Future studies that integrate clinical, molecular, and treatment-related data are needed for advancing understanding of the racial disparity in CRC survival, especially for those <50 years old. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|